×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Wednesday, March 12th 2025
01pm to 01:45pm (GMT+1)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Modérateur :
Pr Florence Joly

Orateurs :
Dr Margaux Renier
Pr Florence Joly
Dr Paule Augereau

Épisode 1 : Découvrez le programme

 

13:00 Introduction
 
13:02 Cas clinique : Carcinose péritonéale endomètre dMMR
Margaux Renier
 
13:12 Quel traitement aujourd'hui ? place IO en association ?
Florence Joly & Paule Augereau
 
13:22 Place IO seule ou des schémas sans chimio ?
Florence Joly & Paule Augereau
 
13:32 En cas de réponse exceptionnelle, y a t-il encore une place pour la chirurgie ?
Florence Joly & Paule Augereau
 
13:42 Débat/Discussion et réponses aux questions
Florence Joly & Paule Augereau
 

Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !

Épisode 2 Cancer de l'endomètre avancé en rechute précoce :que proposer en 2025
RDV le 26 mars 2025 13h
 
Épisode 3 Cancer de l'endomètre avancé pMMR P53 muté
RDV le 9 avril 2025 13h
 
Épisode 4 Cancer de l'endomètre avancé pMMR NSMP
RDV le 29 avril 2025 13h
 

 

Shooting date : 2025-03-12
Last update : 2025-02-14

Suggestions

Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, June 18th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, June 18th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, June 18th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, June 18th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, June 18th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, June 18th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, June 18th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, June 18th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, June 19th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, June 19th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, June 19th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, June 19th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, June 19th 2024 from 06am to 07:30am (GMT+2)

La qualité de vie

et le cancer de l'ovaire

Share
Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 10th 2021 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, November 10th 2021 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 10th 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 10th 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 10th 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 10th 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 10th 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 11th 2021 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 11th 2021 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 11th 2021 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 11th 2021 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 11th 2021 from 05am to 06:30am (GMT+1)

La prise en compte de la qualité de vie, des choix des patientes en cancérologie gynécologique

Comment passer des recommandations de Saint-Paul-de-Vence à la pratique quotidienne ?

Share
Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 20th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, November 20th 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 20th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 20th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 20th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 20th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 20th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 21st 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 21st 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 21st 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 21st 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 21st 2024 from 05am to 06:30am (GMT+1)

Les iPARP dans le cancer de l’ovaire : biologie, rationnel, traitements actuels et perspectives...

Share
Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Honolulu : Wednesday, May 18th 2022 from 07:30am to 09am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 10:30am to 12pm (GMT+2)
New York : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 02:30pm to 04pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 09:30pm to 11pm (GMT+2)
Bangkok : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 02:30am to 04am (GMT+2)
Sydney : Thursday, May 19th 2022 from 04:30am to 06am (GMT+2)
Wellington : Thursday, May 19th 2022 from 06:30am to 08am (GMT+2)

Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

Share